Bio-Rad Laboratories | BIO - Assets


Bio-Rad Laboratories reported $10.25B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.97B 902M Jun/2026
Becton, Dickinson and Co. USD 50.73B 101M Jun/2026
Bio Techne USD 2.59B 36.12M Jun/2026
Bio-Rad Laboratories USD 10.25B 462M Jun/2026
Bruker USD 6.05B 77.8M Jun/2026
Charles River Laboratories USD 7.53B 198.16M Jun/2026
Danaher USD 93.28B 914M Sep/2026
General Electric Aerospace USD 127.2B 477M Sep/2026
Illumina USD 6.65B 91M Jun/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
Laboratory Of America USD 18.92B 392.3M Sep/2026
Merck USD 129.8B 1.12B Jun/2026
Mettler Toledo International USD 3.67B 2.03M Jun/2026
Myriad Genetics USD 638.9M 34.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Pacific Biosciences Of California USD 751.85M 30.51M Jun/2026
Quest Diagnostics USD 17.22B 282M Sep/2026
Repligen USD 2.93B 23.77M Sep/2026
Revvity USD 12.05B 49.24M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Siemens EUR 167.54B 428M Jun/2026
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 114.23B 1.06B Sep/2026
Tosoh JPY 1.47T 59.99B Jun/2026
Waters USD 24.75B 220M Jun/2026